Mirae Asset Global Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-3,013
Closed -$278K – 1763
2021
Q3
$278K Buy
3,013
+286
+10% +$27.5K ﹤0.01% 1627
2021
Q2
$279K Buy
2,727
+190
+7% +$19.1K ﹤0.01% 1595
2021
Q1
$248K Buy
+2,537
New +$231K ﹤0.01% 1456
2020
Q1
– Sell
-3,360
Closed -$264K – 1497
2019
Q4
$264K Buy
+3,360
New +$248K ﹤0.01% 1374

Other funds holding USNA

Mirae Asset Global Investments's USNA Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Usana Health Sciences (USNA) in Q4 2021, closing a stake of 3,013 shares — an estimated $278K sold.

Mirae Asset Global Investments first reported a position in USNA in Q4 2019 and held it in 4 quarters. The position peaked at $279K in Q2 2021. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2021.

  • Mirae Asset Global Investments reported no remaining Usana Health Sciences position as of Q4 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,013 Usana Health Sciences shares in Q4 2021, an estimated $278K.
  • Mirae Asset Global Investments first reported a position in Usana Health Sciences in Q4 2019 and held it in 4 quarters.
  • Mirae Asset Global Investments's Usana Health Sciences position peaked at $279K in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.